Core Insights - Polyrizon Ltd. has completed the branding process for its PL-14 allergy blocker, which will be marketed as NASARIX™ [1][4] - NASARIX™ utilizes Polyrizon's proprietary Capture and Contain™ hydrogel technology, designed to create a protective barrier against allergens and viruses [2][5] - The establishment of the NASARIX™ brand is a significant milestone for Polyrizon, aiding in future commercialization and effective communication of the product's benefits [2][4] Company Overview - Polyrizon is a pre-clinical-stage biotechnology company focused on developing innovative medical device hydrogels delivered as nasal sprays [5] - The company's C&C hydrogel technology aims to provide a barrier against viruses and allergens, functioning as a "biological mask" in the nasal cavity [5] - Polyrizon is also developing additional technology for nasal delivery of active pharmaceutical ingredients, referred to as Trap and Target™ [5]
Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX™